TriSalus Life Sciences (TLSI) Year-over-year earnings per share growth for the last twelve months

TriSalus Life Sciences (TLSI) collaboration with oncology centers to improve drug delivery to tumors is reflected in the quarterly EPS growth profile transmitted by the GURU.Markets platform, where 83.40 shows the current value of the metric. The production of infusion systems in Colorado relies on strict raw material control, yet revenue shortfalls and R&D expenses are depleting reserves.

trisaluslifesci.com (TLSI) - Quarterly EPS earnings growth from 02/21/2024 to 11/15/2026

TriSalus Life Sciences, Inc. (TLSI) - metric breakdowns and financial figures

- market value and analyst target forecast:

Price Chart trisaluslifesci.com|TLSI - Average Forecast Price

- market capitalization details:

Market Value TriSalus Life Sciences, Inc.|TLSI - Real Price to Acquire Entire Company

- book capitalization data:

Book Value per Share TriSalus Life Sciences|TLSI - Book Capitalization|Market Capitalization to Book Value Ratio trisaluslifesci.com|TLSI - Cumulative Company Assets

- debt and liquidity details:

Total Debt to Capital TriSalus Life Sciences|TLSI - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio TriSalus Life Sciences|TLSI - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio TriSalus Life Sciences, Inc.|TLSI - Company Long-Term Loans and Borrowings|Company Short-Term Debts TriSalus Life Sciences|Quick Liquidity trisaluslifesci.com

- earnings and valuation multiples indicators:

TLSI - Net Financial Result|Projected Future Earnings TriSalus Life Sciences|TLSI - P/E Multiple|Future Price to Earnings TriSalus Life Sciences|TLSI - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio TriSalus Corp|TLSI - Operating profit EBITDA|Earnings per share for the last twelve months TriSalus Life Sciences|TLSI - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months trisaluslifesci.com|TLSI - Earnings per share increase in current year|Net earnings per share growth forecast for next year TriSalus Life Sciences

- revenue and sales details:

TLSI - Company Revenue|Projected Sales Volume TriSalus Corp|TLSI - Price-to-Revenue Coefficient|Forward P/S Multiple TriSalus Corp|TLSI - Trailing Twelve Months Sales Growth

Fundamental company valuation:TriSalus Life Sciences

Flagship merchandise of trisaluslifesci.com

This metric is calculated as the percentage change in net income per share relative to the same period last year. It measures the dynamics of asset monetization and the efficiency of capital management. For TriSalus Life Sciences (TLSI), this rate reflects the financial return from the synergy between drug development and targeted delivery systems. An investor can assess the sustainability of the company's market niche based on quarterly EPS growth. The dynamics of this indicator signal a phase of expansion or contraction of the operating margin.

Who TriSalus Life Sciences competes with

renovorx.com (RNXT) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months PharmaCyte (PMCB)